Absence of Differential Cyclin D1 Immunohistochemical Protein Expression in Nevi and Melanoma Evaluated by Digital Image Analysis

被引:1
作者
Koh, Stephen S. [1 ]
Lau, Sean K. [1 ]
Cassarino, David S. [2 ]
机构
[1] Irvine Med Ctr, Dept Pathol & Dermatopathol, Southern Calif Permanente Med Grp, Kaiser Permanente Anaheim, 3430 East Palma Ave, Anaheim, CA 92806 USA
[2] Kaiser Permanente Los Angeles Med Ctr, Los Angeles, CA USA
关键词
immunohistochemistry; cyclin D1; nevi; melanoma; digital imaging; MALIGNANT-MELANOMA; P16; PROGRESSION; LANDSCAPE;
D O I
10.1097/PAI.0000000000001026
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Background: Distinction of superficial spreading melanoma (SSM) from compound nevi (CN) sometimes poses difficult diagnostic challenges. Herein, we studied cyclin D1 protein expression by immunohistochemistry in SSM and CN and evaluated the results by digital image analysis. Design: A total of 13 CN and 12 SSM cases were retrospectively reviewed and cyclin D1 immunohistochemistry was performed. Immunohistochemical stained slides were evaluated by digital imaging analysis that included quantification and staining intensity of the cyclin D1 expressing dermal cells. Results: Cyclin D1 expression was observed in all CN and SSM. CN-positive staining was present in 30% to 93% of the dermal nevocytes, more positive in the upper (mean 85%), than lower half (mean 57%). SSM-positive staining was present in 44% to 96% of the dermal lesion, more positive in the upper (mean 88%) than lower half (mean 49%). When analyzed based on 3+ strong staining intensity, similar regional differences in cyclin D1 expression were observed. Conclusions: Digital image analysis of Cyclin D1 expression showed no differences between CN and SSM. Quantity and regional distribution of cyclin D1 positivity were found to be similar in both lesions. Our findings argue against the routine use of cyclin D1 immunohistochemistry as a diagnostic tool for differentiating CN from SSM.
引用
收藏
页码:441 / 445
页数:5
相关论文
共 23 条
[1]   Progression in cutaneous malignant melanoma is associated with distinct expression profiles -: A tissue microarray-based study [J].
Alonso, SR ;
Ortiz, P ;
Pollán, M ;
Pérez-Gómez, B ;
Sánchez, L ;
Acuña, MJ ;
Pajares, R ;
Martínez-Tello, FJ ;
Hortelano, CM ;
Piris, MA ;
Rodríguez-Peralto, JL .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (01) :193-203
[2]   Immunohistochemical Expression of p16, p21, p27 and Cyclin D1 in Oral Nevi and Melanoma [J].
Bruno Augusto Benevenuto de Andrade ;
Jorge Esquiche León ;
Román Carlos ;
Wilson Delgado-Azañero ;
Adalberto Mosqueda-Taylor ;
Oslei Paes de Almeida .
Head and Neck Pathology, 2012, 6 (3) :297-304
[3]   The landscape of somatic copy-number alteration across human cancers [J].
Beroukhim, Rameen ;
Mermel, Craig H. ;
Porter, Dale ;
Wei, Guo ;
Raychaudhuri, Soumya ;
Donovan, Jerry ;
Barretina, Jordi ;
Boehm, Jesse S. ;
Dobson, Jennifer ;
Urashima, Mitsuyoshi ;
Mc Henry, Kevin T. ;
Pinchback, Reid M. ;
Ligon, Azra H. ;
Cho, Yoon-Jae ;
Haery, Leila ;
Greulich, Heidi ;
Reich, Michael ;
Winckler, Wendy ;
Lawrence, Michael S. ;
Weir, Barbara A. ;
Tanaka, Kumiko E. ;
Chiang, Derek Y. ;
Bass, Adam J. ;
Loo, Alice ;
Hoffman, Carter ;
Prensner, John ;
Liefeld, Ted ;
Gao, Qing ;
Yecies, Derek ;
Signoretti, Sabina ;
Maher, Elizabeth ;
Kaye, Frederic J. ;
Sasaki, Hidefumi ;
Tepper, Joel E. ;
Fletcher, Jonathan A. ;
Tabernero, Josep ;
Baselga, Jose ;
Tsao, Ming-Sound ;
Demichelis, Francesca ;
Rubin, Mark A. ;
Janne, Pasi A. ;
Daly, Mark J. ;
Nucera, Carmelo ;
Levine, Ross L. ;
Ebert, Benjamin L. ;
Gabriel, Stacey ;
Rustgi, Anil K. ;
Antonescu, Cristina R. ;
Ladanyi, Marc ;
Letai, Anthony .
NATURE, 2010, 463 (7283) :899-905
[4]   Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present [J].
Casimiro, Mathew C. ;
Velasco-Velazquez, Marco ;
Aguirre-Alvarado, Charmina ;
Pestell, Richard G. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (03) :295-304
[5]   Melanocytic nevi in pregnancy: histologic features and Ki-67 proliferation index [J].
Chan, May P. ;
Chan, Maren M. ;
Tahan, Steven R. .
JOURNAL OF CUTANEOUS PATHOLOGY, 2010, 37 (08) :843-851
[6]   The effect of the sun on expression of β-catenin, p16 and cyclin d1 proteins in melanocytic lesions [J].
Demirkan, N. C. ;
Kesen, Z. ;
Akdag, B. ;
Larue, L. ;
Delmas, V. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2007, 32 (06) :733-739
[7]   Cyclin D1 and p16 Expression in Blue Nevi and Malignant Melanoma [J].
Donigan, Jessica M. ;
De Luca, Jacqueline ;
Lum, Christopher .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2017, 25 (02) :91-94
[8]  
Elder D. E., 2017, WHO classification of skin tumours
[9]   Evidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologists [J].
Emanuel, Patrick O. ;
Andea, Aleodor A. ;
Vidal, Claudia I. ;
Missall, Tricia A. ;
Novoa, Roberto A. ;
Bohlke, Angela K. ;
Hughes, Sarah R. ;
Hurley, Maria Y. ;
Kim, Jinah .
JOURNAL OF CUTANEOUS PATHOLOGY, 2018, 45 (11) :839-846
[10]   Immunohistochemistry in Dermatopathology [J].
Ferringer, Tammie .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (01) :83-105